These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 27178057)

  • 21. A20 targets PFKL and glycolysis to inhibit the progression of hepatocellular carcinoma.
    Feng Y; Zhang Y; Cai Y; Liu R; Lu M; Li T; Fu Y; Guo M; Huang H; Ou Y; Chen Y
    Cell Death Dis; 2020 Feb; 11(2):89. PubMed ID: 32015333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PES1 is transcriptionally regulated by BRD4 and promotes cell proliferation and glycolysis in hepatocellular carcinoma.
    Fan P; Wang B; Meng Z; Zhao J; Jin X
    Int J Biochem Cell Biol; 2018 Nov; 104():1-8. PubMed ID: 30172011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. By reducing hexokinase 2, resveratrol induces apoptosis in HCC cells addicted to aerobic glycolysis and inhibits tumor growth in mice.
    Dai W; Wang F; Lu J; Xia Y; He L; Chen K; Li J; Li S; Liu T; Zheng Y; Wang J; Lu W; Zhou Y; Yin Q; Abudumijiti H; Chen R; Zhang R; Zhou L; Zhou Z; Zhu R; Yang J; Wang C; Zhang H; Zhou Y; Xu L; Guo C
    Oncotarget; 2015 May; 6(15):13703-17. PubMed ID: 25938543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phosphoglucomutase 1 inhibits hepatocellular carcinoma progression by regulating glucose trafficking.
    Jin GZ; Zhang Y; Cong WM; Wu X; Wang X; Wu S; Wang S; Zhou W; Yuan S; Gao H; Yu G; Yang W
    PLoS Biol; 2018 Oct; 16(10):e2006483. PubMed ID: 30335765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ZNF692 drives malignant development of hepatocellular carcinoma cells by promoting ALDOA-dependent glycolysis.
    Meng W; Lu X; Wang G; Xiao Q; Gao J
    Funct Integr Genomics; 2024 Mar; 24(2):53. PubMed ID: 38453820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glycogen synthase kinase-3β inhibition promotes lysosome-dependent degradation of c-FLIP
    Zhang N; Liu X; Liu L; Deng Z; Zeng Q; Pang W; Liu Y; Song D; Deng H
    Cell Death Dis; 2018 Feb; 9(2):230. PubMed ID: 29445085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PKM2 is the target of proanthocyanidin B2 during the inhibition of hepatocellular carcinoma.
    Feng J; Wu L; Ji J; Chen K; Yu Q; Zhang J; Chen J; Mao Y; Wang F; Dai W; Xu L; Wu J; Guo C
    J Exp Clin Cancer Res; 2019 May; 38(1):204. PubMed ID: 31101057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genistein suppresses aerobic glycolysis and induces hepatocellular carcinoma cell death.
    Li S; Li J; Dai W; Zhang Q; Feng J; Wu L; Liu T; Yu Q; Xu S; Wang W; Lu X; Chen K; Xia Y; Lu J; Zhou Y; Fan X; Mo W; Xu L; Guo C
    Br J Cancer; 2017 Nov; 117(10):1518-1528. PubMed ID: 28926527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. E3 ligase ZFP91 inhibits Hepatocellular Carcinoma Metabolism Reprogramming by regulating PKM splicing.
    Chen D; Wang Y; Lu R; Jiang X; Chen X; Meng N; Chen M; Xie S; Yan GR
    Theranostics; 2020; 10(19):8558-8572. PubMed ID: 32754263
    [No Abstract]   [Full Text] [Related]  

  • 30. Transcription Factor MAZ Potentiates the Upregulated NEIL3-mediated Aerobic Glycolysis, thereby Promoting Angiogenesis in Hepatocellular Carcinoma.
    Zhang F; Wang B; Zhang W; Xu Y; Zhang C; Xue X
    Curr Cancer Drug Targets; 2024; 24(12):1235-1249. PubMed ID: 38347781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression and biological significance of c-FLIP in human hepatocellular carcinomas.
    Du X; Bao G; He X; Zhao H; Yu F; Qiao Q; Lu J; Ma Q
    J Exp Clin Cancer Res; 2009 Feb; 28(1):24. PubMed ID: 19232089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aerobic glycolysis and tumor progression of hepatocellular carcinoma are mediated by ubiquitin of P53 K48-linked regulated by TRIM37.
    Ge Y; Zhao R; Li B; Xiao B; Zhou L; Zuo S
    Exp Cell Res; 2022 Dec; 421(2):113377. PubMed ID: 36252649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. USP8 suppresses death receptor-mediated apoptosis by enhancing FLIP
    Jeong M; Lee EW; Seong D; Seo J; Kim JH; Grootjans S; Kim SY; Vandenabeele P; Song J
    Oncogene; 2017 Jan; 36(4):458-470. PubMed ID: 27321185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
    Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
    Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
    Zhou M; Zhang XY; Yu X
    Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quercetin sensitizes human hepatoma cells to TRAIL-induced apoptosis via Sp1-mediated DR5 up-regulation and proteasome-mediated c-FLIPS down-regulation.
    Kim JY; Kim EH; Park SS; Lim JH; Kwon TK; Choi KS
    J Cell Biochem; 2008 Dec; 105(6):1386-98. PubMed ID: 18980244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
    Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
    BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibitor of differentiation 1 transcription factor promotes metabolic reprogramming in hepatocellular carcinoma cells.
    Sharma BK; Kolhe R; Black SM; Keller JR; Mivechi NF; Satyanarayana A
    FASEB J; 2016 Jan; 30(1):262-75. PubMed ID: 26330493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long noncoding RNA AFAP1-AS1 indicates a poor prognosis of hepatocellular carcinoma and promotes cell proliferation and invasion via upregulation of the RhoA/Rac2 signaling.
    Zhang JY; Weng MZ; Song FB; Xu YG; Liu Q; Wu JY; Qin J; Jin T; Xu JM
    Int J Oncol; 2016 Apr; 48(4):1590-8. PubMed ID: 26892468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phosphorylation of PPARγ at Ser84 promotes glycolysis and cell proliferation in hepatocellular carcinoma by targeting PFKFB4.
    Shu Y; Lu Y; Pang X; Zheng W; Huang Y; Li J; Ji J; Zhang C; Shen P
    Oncotarget; 2016 Nov; 7(47):76984-76994. PubMed ID: 27769068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.